Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is the most common type of baldness treated with corticosteroids and minoxidil.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

The document doesn't say if the treatment for hair loss worked.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Low-level laser therapy can significantly regrow hair in alopecia areata.

Vitamin D3 and anisodamine may help treat hair loss in children.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

Alopecia areata is an autoimmune disease causing hair loss, with treatments often ineffective but new options are being researched.

Alopecia areata is a hair loss condition that may be linked to stress and genetics, often requires psychological support, and has no set treatment.

A child with rough nails also had hair loss and allergies.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

No cure exists for alopecia areata; treatments aim to manage symptoms.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

PUVA-turban therapy can help some people with severe alopecia areata regrow hair.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

Hair color is not a risk factor for developing alopecia areata.

Children with alopecia areata and their caregivers experience significant emotional and quality of life challenges.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Baricitinib is effective for severe alopecia areata but has some side effects.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

New treatments for sudden hair loss include oral medications and a special laser, both showing promise in hair regrowth.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Animal models have helped understand hair loss from alopecia areata and find new treatments.